Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study

The Lancet Rheumatology 2026

View at publisher
Authors: Chiara Tani, Chiara Cardelli, Luca Moroni, Margherita Zen, Francesca Bottazzi, Micaela Fredi, Alessandra Bortoluzzi, Matteo Piga, Flavia Riccio, Fulvia Ceccarelli, Ginevra De Marchi, Lucia Manfredi
+37 more Rita Mulè, Edoardo Biancalana, Mariele Gatto, Laura Coladonato, Paola Conigliaro, Maria Gerosa, Andrea Picchianti Diamanti, Giuseppe Alvise Ramirez, Filippo Vesentini, Giovanni Zanframundo, Chiara Giovannucci Orlandi, Ettore Silvagni, Elisabetta Chessa, Marica Trevisani, Miki Palmerini, Pietro Francesco Gavino Pilo, Sara Ferrigno, ANNA CHIARA DI LOLLO, Silvia Noviello, Alberto Lo Gullo, Maria Ilenia De Andres, Serena Guiducci, Giacomo Emmi, Federica Maiolini, Rossella De Angelis, Roberto Felice Caporali, Florenzo Iannone, G. Moroncini, Luca Quartuccio, Fabrizio Conti, Francesco Ciccia, Marcello Govoni, Franco Franceschini, Lorenzo Cavagna, Luca Iaccarino, Lorenzo DAGNA, Marta Mosca
DOI: 10.1016/s2665-9913(25)00316-9
Cited by: 1
References: 34

Fields of Study & Subjects

Systemic Lupus Erythematosus Research Rheumatoid Arthritis Research and Therapies Liver Diseases and Immunity

Publication details

Journal / source
The Lancet Rheumatology
Publisher
Elsevier BV
Volume
8
Issue
3
Pages
e181–e191
Publication date
5 February 2026
Language
EN